216 related articles for article (PubMed ID: 24318876)
61. Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals.
Jiang F; Yeo CW; Lee SS; Oh MK; Ghim JL; Shon JH; Kim HS; Kim EY; Kim DH; Shin JG
Pharmacogenet Genomics; 2013 Mar; 23(3):175-9. PubMed ID: 23292115
[TBL] [Abstract][Full Text] [Related]
62. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
Wang S; Yuan X; Lu D; Guo L; Wu B
Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
[TBL] [Abstract][Full Text] [Related]
63. Farnesoid X receptor represses hepatic human APOA gene expression.
Chennamsetty I; Claudel T; Kostner KM; Baghdasaryan A; Kratky D; Levak-Frank S; Frank S; Gonzalez FJ; Trauner M; Kostner GM
J Clin Invest; 2011 Sep; 121(9):3724-34. PubMed ID: 21804189
[TBL] [Abstract][Full Text] [Related]
64. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.
Xu J; Christian B; Jump DB
J Biol Chem; 2006 Jul; 281(27):18351-62. PubMed ID: 16644726
[TBL] [Abstract][Full Text] [Related]
65. Bile acids down-regulate the expression of Augmenter of Liver Regeneration (ALR) via SHP/HNF4α1 and independent of Egr-1.
Ibrahim S; Dayoub R; Melter M; Weiss TS
Exp Mol Pathol; 2018 Dec; 105(3):236-242. PubMed ID: 30243934
[TBL] [Abstract][Full Text] [Related]
66. Characterization of the mitochondrial localization of the nuclear receptor SHP and regulation of its subcellular distribution by interaction with Bcl2 and HNF4α.
Zhang Y; Wang L
PLoS One; 2013; 8(7):e68491. PubMed ID: 23874642
[TBL] [Abstract][Full Text] [Related]
67. Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.
Takezawa T; Matsunaga T; Aikawa K; Nakamura K; Ohmori S
Drug Metab Pharmacokinet; 2012; 27(4):430-8. PubMed ID: 22333269
[TBL] [Abstract][Full Text] [Related]
68. Hepatic nuclear factor 4α positively regulates complement C3 expression and does not interfere with TNFα-mediated stimulation of C3 expression in HepG2 cells.
Shavva VS; Mogilenko DA; Dizhe EB; Oleinikova GN; Perevozchikov AP; Orlov SV
Gene; 2013 Jul; 524(2):187-92. PubMed ID: 23628799
[TBL] [Abstract][Full Text] [Related]
69. HNF4α--role in drug metabolism and potential drug target?
Hwang-Verslues WW; Sladek FM
Curr Opin Pharmacol; 2010 Dec; 10(6):698-705. PubMed ID: 20833107
[TBL] [Abstract][Full Text] [Related]
70. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
Li G; Kong B; Zhu Y; Zhan L; Williams JA; Tawfik O; Kassel KM; Luyendyk JP; Wang L; Guo GL
Toxicol Appl Pharmacol; 2013 Oct; 272(2):299-305. PubMed ID: 23811326
[TBL] [Abstract][Full Text] [Related]
71. Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate.
McConnachie L; Bodor M; Kowdley K; Levy A; Tung B; Thummel K; Phillips B; Bajpai M; Chi V; Esmay JD; Shen DD; Ho RJ
Clin Pharmacol Ther; 2004 Apr; 75(4):282-97. PubMed ID: 15060507
[TBL] [Abstract][Full Text] [Related]
72. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.
Ding X; Lichti K; Kim I; Gonzalez FJ; Staudinger JL
J Biol Chem; 2006 Sep; 281(36):26540-51. PubMed ID: 16825189
[TBL] [Abstract][Full Text] [Related]
73. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
74. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
75. Potential role of CYP2D6 in the central nervous system.
Cheng J; Zhen Y; Miksys S; Beyoğlu D; Krausz KW; Tyndale RF; Yu A; Idle JR; Gonzalez FJ
Xenobiotica; 2013 Nov; 43(11):973-84. PubMed ID: 23614566
[TBL] [Abstract][Full Text] [Related]
76. Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism.
Martinez-Jimenez CP; Kyrmizi I; Cardot P; Gonzalez FJ; Talianidis I
Mol Cell Biol; 2010 Feb; 30(3):565-77. PubMed ID: 19933841
[TBL] [Abstract][Full Text] [Related]
77. Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.
Yu AM; Idle JR; Gonzalez FJ
Drug Metab Rev; 2004 May; 36(2):243-77. PubMed ID: 15237854
[TBL] [Abstract][Full Text] [Related]
78. Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy.
Topletz AR; Le HN; Lee N; Chapman JD; Kelly EJ; Wang J; Isoherranen N
Drug Metab Dispos; 2013 Feb; 41(2):312-9. PubMed ID: 23150428
[TBL] [Abstract][Full Text] [Related]
79. Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver.
Kazantseva YA; Yarushkin AA; Mostovich LA; Pustylnyak YA; Pustylnyak VO
Toxicol Appl Pharmacol; 2015 Oct; 288(1):26-32. PubMed ID: 26171734
[TBL] [Abstract][Full Text] [Related]
80. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.
Tirona RG; Lee W; Leake BF; Lan LB; Cline CB; Lamba V; Parviz F; Duncan SA; Inoue Y; Gonzalez FJ; Schuetz EG; Kim RB
Nat Med; 2003 Feb; 9(2):220-4. PubMed ID: 12514743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
